← Eichor
Condition: Vedolizumab Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Vedolizumab

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Efficacy and Safety of Vedolizumab Combined With Upadacitinib in Patients With Ulcerative Colitis
NA · 1 location(s) · Sixth Affiliated Hospital, Sun Yat-sen University · NCT06095596The PODIUM Study - a Three-arm Comparison of Target Therapies After Anti-TNFα in Ulcerative Colitis
Phase N/A · 1 location(s) · Humanitas Clinical and Research Center · NCT06691061A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
Phase 4 · 53 location(s) · Takeda · NCT06045754Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease
Phase N/A · 6 location(s) · Mercy Medical Center · NCT06750731VOICE-Early Response to Vedolizumab and IL-23 Antagonists in Participants With Crohn's Disease: A Prospective Observatio
Phase N/A · 25 location(s) · Alimentiv Inc. · NCT06249555Value of IUS in Predicting Vedolizumab Efficacy and Assessing Transmural Healing in Early Crohn's Disease: A Multicenter
Phase N/A · 1 location(s) · The Third Xiangya Hospital of Central South University · NCT07093294High Dose Interval Vitamin D Supplementation in Patients With Inflammatory Bowel Disease Receiving Biologic Therapy
Phase N/A · 1 location(s) · Boston Children's Hospital · NCT04331639A Study of Vedolizumab in Adults With Ulcerative Colitis or Crohn's Disease in the Community Setting
Phase 4 · 101 location(s) · Takeda · NCT06581328Preventing of GVHD with Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Ruxolitinib At Children and Yo
Phase 2/Phase 3 · 1 location(s) · Federal Research Institute of Pediatric Hematology, Oncology · NCT06756152A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease
Phase 3 · 138 location(s) · Takeda · NCT06227910The Efficacy and Safety of Combining Probiotic VSL#3 With Vedolizumab for the Treatment of Moderate Ulcerative Colitis
Phase 4 · 12 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT06609447Early Vedolizumab as First-Line for Immune-Related Colitis Therapy Trial
Phase 2 · 2 location(s) · Shilpa Grover, MD, MPH · NCT06841705A Study of Vedolizumab SC Given to Adults With Moderate to Severe Ulcerative Colitis or Crohn's Disease in South Korea
Phase N/A · 1 location(s) · Takeda · NCT05428345A Study of Vedolizumab in Adult Participants With Moderate to Severe Crohn's Disease
Phase 3 · 41 location(s) · Takeda · NCT05837897COMPARE - Pediatric Inflammatory Bowel Disease (PIBD)
Phase N/A · 4 location(s) · University of North Carolina, Chapel Hill · NCT07198113A Study to Learn About the Safety of Vedolizumab and How Well it Works in Children and Teenagers With Active Chronic Pou
Phase 3 · 14 location(s) · Takeda · NCT06443502Prediction Model for Response to Biologics and Small Molecular Agent for UC
Phase N/A · 1 location(s) · Asan Medical Center · NCT05186623Comparison of Vedolizumab Treatment to Adalimumab Dose Intensification in Crohn's Disease Patients With Loss of Response
Phase 4 · 12 location(s) · Centre Hospitalier Universitaire de Saint Etienne · NCT06180382Autologous Stem Cell Transplant for Crohn's Disease
Phase 2 · 1 location(s) · Aaron Etra · NCT03219359A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD
Phase 3 · 54 location(s) · Takeda · NCT06405087Therapeutic Drug Monitoring for Biological Therapy in Pediatric Inflammatory Bowel Disease
Phase N/A · 10 location(s) · Medical University Innsbruck · NCT06954311A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Phase 3 · 98 location(s) · Takeda · NCT05442567A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
Phase 4 · 49 location(s) · Takeda · NCT06095128Safety and Efficacy of OD-07656 and of Subsequent Vedolizumab Therapy in Moderately to Severely Active Ulcerative Coliti
Phase 2 · 32 location(s) · Odyssey Therapeutics · NCT06850727LFMT vs Placebo in New Biologic Start for Ulcerative Colitis
Phase 2 · 1 location(s) · University of Alberta · NCT05327790Impact of Anti-TNF, Vedolizumab and Tofacitinib on Aortic Stiffness, Carotid Intima-media Thickness and Cardiovascular R
Phase 4 · 1 location(s) · Centre Hospitalier Universitaire, Amiens · NCT04743518Subcutaneous Interval Lengthening of Vedolizumab for Economic Research
Phase 4 · 1 location(s) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC · NCT06584162A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
Phase 3 · 54 location(s) · Takeda · NCT06100289A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)
Phase 3 · 96 location(s) · Takeda · NCT04779320Real-World Effectiveness and Safety of Upadacitinib Plus Vedolizumab vs Upadacitinib Monotherapy During Induction in Mod
Phase N/A · 1 location(s) · Sixth Affiliated Hospital, Sun Yat-sen University · NCT07442045
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.